A Case of New-Onset Systemic Lupus Erythematosus With Serositis in a Maintenance Hemodialysis Patient.
Systemic lupus erythematosus
hemodialysis
pericarditis
peritonitis
pleuritis
serositis
Journal
Clinical medicine insights. Case reports
ISSN: 1179-5476
Titre abrégé: Clin Med Insights Case Rep
Pays: United States
ID NLM: 101531893
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
07
2021
accepted:
06
10
2021
entrez:
1
11
2021
pubmed:
2
11
2021
medline:
2
11
2021
Statut:
epublish
Résumé
A 61-year-old woman with a 4-year history of maintenance hemodialysis due to end-stage renal disease of unknown cause was admitted because of a recurrent fever and abdominal pain lasting for 3 months. She had rheumatoid arthritis as a complication and had taken sulfasalazine for over 4 years. Laboratory data revealed thrombocytopenia, hypocomplementemia, a high C-reactive protein level, and positivity for antinuclear antibody and anti-double strand DNA antibody. Gallium scintigraphy showed pericarditis, pleuritis, and peritonitis. Nonscarring alopecia was also noted. She was diagnosed as having systemic lupus erythematosus (SLE). Drug-induced lupus elicited by sulfasalazine was ruled out because the symptoms did not improve even after the discontinuation of the drug upon admission. Oral prednisolone treatment markedly improved her symptoms and laboratory data. However, she later died of sepsis arising from proctitis on day 71 of admission. This report underscores the necessity of considering new-onset SLE in patients with unexplained fever and serositis, including pleuritis, peritonitis, or pericarditis, even if they are receiving maintenance dialysis.
Identifiants
pubmed: 34720604
doi: 10.1177/11795476211056172
pii: 10.1177_11795476211056172
pmc: PMC8554544
doi:
Types de publication
Case Reports
Langues
eng
Pagination
11795476211056172Informations de copyright
© The Author(s) 2021.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Autoimmun Rev. 2008 Jan;7(3):235-9
pubmed: 18190884
Autoimmun Rev. 2018 Sep;17(9):912-918
pubmed: 30005854
J Ren Nutr. 2012 Jan;22(1):149-56
pubmed: 22200433
CEN Case Rep. 2013 May;2(1):46-48
pubmed: 28509221
J Clin Rheumatol. 1996 Jun;2(3):160-2
pubmed: 19078053
Medicine (Baltimore). 2004 Nov;83(6):348-359
pubmed: 15525847
Arch Dermatol Res. 2009 Jan;301(1):99-105
pubmed: 18797892
Am J Nephrol. 1992;12(1-2):105-7
pubmed: 1415353
CEN Case Rep. 2015 Nov;4(2):139-144
pubmed: 28509090
Gastroenterology. 1991 Jun;100(6):1737-42
pubmed: 2019378
Am J Kidney Dis. 1990 Sep;16(3):189-95
pubmed: 2399912
Dtsch Arztebl Int. 2015 Jun 19;112(25):423-32
pubmed: 26179016
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462
N Engl J Med. 1983 Jan 27;308(4):186-90
pubmed: 6336825
J Clin Rheumatol. 2012 Mar;18(2):67-70
pubmed: 22334266